BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16095998)

  • 1. Molecular mechanisms in gliomagenesis.
    Hulleman E; Helin K
    Adv Cancer Res; 2005; 94():1-27. PubMed ID: 16095998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the study of brain tumor stem cells as treatment targets].
    Hide T; Kuratsu J
    Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways regulating gliomagenesis.
    Konopka G; Bonni A
    Curr Mol Med; 2003 Feb; 3(1):73-84. PubMed ID: 12558076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.
    Fomchenko EI; Holland EC
    Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliomagenesis: genetic alterations and mouse models.
    Holland EC
    Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between stem cells from the adult human brain and from brain tumors.
    Varghese M; Olstorn H; Sandberg C; Vik-Mo EO; Noordhuis P; Nistér M; Berg-Johnsen J; Moe MC; Langmoen IA
    Neurosurgery; 2008 Dec; 63(6):1022-33; discussion 1033-4. PubMed ID: 19057315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biology of gliomas].
    Ducray F
    Cancer Radiother; 2008 Nov; 12(6-7):663-8. PubMed ID: 18838326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma oncogenesis and animal models of glioma formation.
    Lyustikman Y; Lassman AB
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1193-214. PubMed ID: 17113459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.